Tokyo, June 24 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062028) titled 'Characterization of the temporo-parietal junction using multimodal brain imaging and its application to perceptual learning' on June 24.
Study Type:
Observational
Primary Sponsor:
Institute - Niigata University of Health and Welfare
Condition:
Condition - Healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the relationship between somatosensory function (two-point discrimination) and gray matter volume, neurotransmitter (e.g., GABA) concentration, white matter microstructure, and functional networks centered on the temporo-parietal junction (TPJ).
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - Healthy adults aged 18-35 years who can understand the explanation of the experiment and provide voluntary written informed consent.
Key exclusion criteria - History of neurological disease (e.g., stroke, epilepsy) or psychiatric disease (e.g., depression, schizophrenia); use of drugs affecting the central nervous system; claustrophobia; metal implants in the body; pregnancy; any item applicable on the MRI screening questionnaire.
Target Size - 65
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 04 Month 16 Day
Date of IRB - 2026 Year 06 Month 09 Day
Anticipated trial start date - 2026 Year 06 Month 24 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070977
Disclaimer: Curated by HT Syndication.
